The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cleveland Paul B since 2010.
The trader's CIK number is 1376797.
At the time of the last reporting, Cleveland Paul B was the EVP, Corp. Development and CFO of Sangamo Therapeutics, Inc. (stock ticker symbol SGMO).
Also see all insider trading activities at Sangamo Therapeutics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | SGMO | 0 | $0 | 8,333 | $155,693 | 8,333 | $41,914 |
| 2013 | SGMO | 0 | $0 | 35,278 | $377,427 | 35,278 | $140,667 |
| 2011 | SGMO | 0 | $0 | 1,388 | $12,492 | 1,388 | $2,831 |
| 2010 | SGMO | 0 | $0 | 43,334 | $303,338 | 43,334 | $121,398 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | AFFY | 0 | $0 | 55,935 | $1,052,696 | 52,935 | $230,796 |
1. Sangamo Therapeutics, Inc (SGMO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-15 | SGMO | Sale | 8,333 | 18.68 | 155,693 |
| 2014-01-15 | SGMO | Option Ex | 8,333 | 5.03 | 41,914 |
| 2013-12-02 | SGMO | Option Ex | 10,000 | 6.41 | 64,100 |
| 2013-12-02 | SGMO | Sale | 10,000 | 11.64 | 116,390 |
| 2013-10-21 | SGMO | Option Ex | 10,000 | 4.54 | 45,400 |
| 2013-10-21 | SGMO | Sale | 10,000 | 10.93 | 109,340 |
| 2013-09-03 | SGMO | Option Ex | 7,278 | 2.04 | 14,847 |
| 2013-09-03 | SGMO | Sale | 7,278 | 10.30 | 74,977 |
| 2013-07-15 | SGMO | Option Ex | 8,000 | 2.04 | 16,320 |
| 2013-07-15 | SGMO | Sale | 8,000 | 9.59 | 76,720 |
| 2011-02-28 | SGMO | Sale | 1,388 | 9.00 | 12,492 |
| 2011-02-28 | SGMO | Option Ex | 1,388 | 2.04 | 2,831 |
| 2010-12-22 | SGMO | Option Ex | 32,037 | 3.07 | 98,353 |
| 2010-12-22 | SGMO | Sale | 32,037 | 7.00 | 224,259 |
| 2010-12-20 | SGMO | Option Ex | 11,297 | 2.04 | 23,045 |
| 2010-12-20 | SGMO | Sale | 11,297 | 7.00 | 79,079 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-02-25 | AFFY | Option Ex | 52,935 | 4.36 | 230,796 |
| 2010-02-25 | AFFY | Sale | 55,935 | 18.82 | 1,052,696 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cleveland Paul B (EVP, Corp. Development and CFO of Sangamo Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.